About
Guided by our values, we are an impact-driven organization that improves care in every setting – one product, one partner, one patient at a time.
Guided by our values, we are an impact-driven organization that improves care in every setting – one product, one partner, one patient at a time.
Through our core commitments, we are leveraging our scale for the greater good, such as serving the needs of our stakeholders, donating back to our communities, protecting our planet, working with policymakers, and more.
Every year, we publish updates to our commitments through our Impact Report.
Download Our Impact ReportOur businesses bring together leading technologies, innovative solutions and hands-on expertise to support the entire healthcare ecosystem.
We distribute pharmaceuticals and medical supplies to healthcare settings across North America, from pharmacies and hospitals to doctors’ offices and clinics.
We help to ensure the financial wellbeing of pharmacies and health systems and support a stable work environment for their employees.
We provide research, insights, technologies and other support to help address challenges in cancer and specialty care.
We provide a suite of solutions designed to address access, affordability and adherence challenges by bridging the gaps between biopharma companies, pharmacies, providers, and payers to help patients get on and stay on their medications.
We offer solutions that enable employers, payers, health-plan brokers and government agencies to provide lower-cost options for prescription medications and therapies.
We help to ensure the financial wellbeing of pharmacies and health systems and support a stable work environment for their employees.
Every year, we publish updates to our commitments through our Impact Report.
Download Our Impact ReportIRVING, Texas, September 18, 2025 -- 51Âþ»app (NYSE: MCK) today announced changes to its reportable segments and organizational structure, effective in the second quarter of fiscal year 2026. The new reporting structure enhances strategic alignment and transparency, supporting optimizing portfolio management to drive sustainable long-term value creation for shareholders.
“51Âþ»apphas a long history of leadership in healthcare, continuously evolving to meet the needs of our customers, providers, and the patients we collectively serve,” said Britt Vitalone, chief financial officer. “This updated reporting structure reflects a strategic evolution of our business – accelerating growth in the high-margin areas of oncology, multispecialty, and biopharma services. It enhances transparency and reinforces our disciplined approach to capital allocation and shareholder value creation.”
Additional details will be shared during the company’s upcoming Investor Day on Tuesday, September 23, 2025.
The new reportable segments are:
Please refer to a separate 8-K submitted today with the Securities and Exchange Commission for supplemental historical information by new reportable segments for the fiscal quarters ending June 30, 2024, September 30, 2024, December 31, 2024, March 31, 2025, and June 30, 2025, for the fiscal years ending March 31, 2024, and 2025.
Upcoming Investor Day
51Âþ»appwill host its Investor Day on Tuesday, September 23, 2025 at 9:30 AM ET. The event will feature presentations by McKesson’s leadership team and a live Q&A session with chief executive officer Brian Tyler and chief financial officer Britt Vitalone. The video webcast and additional details will be available on McKesson’s Investor Relations website.
About 51Âþ»app
51Âþ»app is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services to help make quality care more accessible and affordable. Learn more about how 51Âþ»appis impacting virtually every aspect of healthcare at McKesson.com and read Stories & Insights.
We routinely use our website, , to post information that may be material to investors, such as business developments, earnings, and financial performance, as well as presentation materials and details for upcoming and past events.